Cargando…
Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer
Autophagy is a cellular degrading process that promotes tumor cell survival or cell death in cancer, depending on the progress of oncogenesis. Protein light chain 3 (LC3) and p62/SQSTM1 (p62) are associated with autophagosomal membranes that engulf cytoplasmic content for subsequent degradation. We...
Autores principales: | Schläfli, Anna M., Adams, Olivia, Galván, José A., Gugger, Mathias, Savic, Spasenija, Bubendorf, Lukas, Schmid, Ralph A., Becker, Karl-Friedrich, Tschan, Mario P., Langer, Rupert, Berezowska, Sabina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129952/ https://www.ncbi.nlm.nih.gov/pubmed/27250032 http://dx.doi.org/10.18632/oncotarget.9647 |
Ejemplares similares
-
Prognostic relevance of autophagy markers LC3B and p62 in esophageal adenocarcinomas
por: Adams, Olivia, et al.
Publicado: (2016) -
Reliable LC3 and p62 Autophagy Marker Detection in Formalin Fixed Paraffin Embedded Human Tissue by Immunohistochemistry
por: Schläfli, A.M., et al.
Publicado: (2015) -
Expression Analysis of Autophagy Related Markers LC3B, p62 and HMGB1 Indicate an Autophagy-Independent Negative Prognostic Impact of High p62 Expression in Pulmonary Squamous Cell Carcinomas
por: Langer, Rupert, et al.
Publicado: (2018) -
Expression analysis of LC3B and p62 indicates intact activated autophagy is associated with an unfavorable prognosis in colon cancer
por: Niklaus, Monique, et al.
Publicado: (2017) -
A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas
por: Adams, Olivia, et al.
Publicado: (2018)